上市公司 Propanc Biopharma 計劃收購 1 億美元以太坊
ChainCatcher 消息，生物製藥公司 Propanc Biopharma (納斯達克股票代碼: PPCB) 宣布計劃在未來 12 個月內收購價值 1 億美元的以太坊
該公司表示，此舉將增強其在加密貨幣投資、藥物開發和資產收購等多方面的企業戰略
風險提示 風險提示
關聯標籤
關聯標籤
掃碼下載
BTC $77,764.47 +4.70%
ETH $2,442.01 +4.93%
BNB $642.86 +3.22%
XRP $1.49 +5.18%
SOL $89.81 +4.13%
TRX $0.3248 -0.64%
DOGE $0.1008 +4.99%
ADA $0.2648 +5.95%
BCH $460.61 +4.80%
LINK $9.77 +4.78%
HYPE $44.89 +0.28%
AAVE $116.30 +8.52%
SUI $1.03 +5.67%
XLM $0.1747 +8.18%
ZEC $343.01 +2.19% BTC $77,764.47 +4.70% ETH $2,442.01 +4.93% BNB $642.86 +3.22% XRP $1.49 +5.18% SOL $89.81 +4.13% TRX $0.3248 -0.64% DOGE $0.1008 +4.99% ADA $0.2648 +5.95% BCH $460.61 +4.80% LINK $9.77 +4.78% HYPE $44.89 +0.28% AAVE $116.30 +8.52% SUI $1.03 +5.67% XLM $0.1747 +8.18% ZEC $343.01 +2.19%
風險提示 風險提示
ChainCatcher 與創新者共建Web3世界
